After peptide stimulation in the presence of anti-IL10 blockade, the frequency of MSLN-specific CD8+ T cells was increased in PBMC of 2 out of 7 patients with pancreatic cancer.. The gene discussed is CD8A; the disease is pancreatic neoplasm.